EORTC-NCI-ASCO Annual Meeting on “Molecular Markers in Cancer”
From 15 November (afternoon) to 17 November 2007
with a tutorial on 14 November, and 15 November (morning)
Sheraton Brussels - Hotel & Towers, 3 Place Rogier, 1210 Brussels, Belgium
We are pleased to announce the tutorial sessions for industry representatives and for selected young oncologists/scientists on 14 and 15 November 2007, prior to the main meeting.
The tutorial is designed to address critical issues industry must consider as they make decisions regarding development of new tools to aid clinical decision-making for patients with cancer. The tutorial will be spent problem-solving, and the didactic presentations will be focused on the issues raised in diagnostic challenges.
Participants will work in teams to put together development plans for assays that will aid clinical decisions in the areas of early detection and targeted therapies. We expect this to be a thought-provoking and productive course for both faculty and participants.
N. Brünner (Denmark), R. Schilsky (USA), F. Sweep (The Netherlands), S. Taube (USA)
J. Bogaerts (Belgium), L. Collette (Belgium), A. Eggermont (The Netherlands), R. Becker (USA), D. Hayes (USA), J. M. Jessup (USA),
T. Lively (USA), L. McShane (USA), F. Pignatti (United Kingdom), E. Russek-Cohen (USA), R. Stupp (Switzerland),
P. Therasse (Belgium), N. Harbeck (Germany)
Session 1 - OVERVIEW, GENERAL PRINCIPLES & CLINICAL SCENARIOS
Session 2 - REGULATORY ISSUES & WORKING BREAKOUT SESSIONS
Session 3 - PRESENTATIONS : CRITIQUES OF DEVELOPMENT PLANS
Main Meeting Program
Main meeting announcement
Session 1 - ASSESSMENT OF BIOMARKERS IN TUMOR TISSUES AND BLOOD
Session 2 - IMAGING BIOMARKERS
Session 3 - ASSESSMENT OF TUMOR BIOMARKERS AT THE GENE AND PROTEIN LEVEL
Session 4 - MOLECULAR MARKERS PREDICTIVE FOR THERAPEUTIC BENEFIT
EORTC is supported by the Belgian National Lottery and by the Belgian Federal Science Policy Office